SCHEMBL11299962

SCHEMBL11299962

COC(=O)c1ccc(N(c2cccc3ccc(=O)[nH]c23)C2CCNC2)cc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 13/20 0.39
▸ SLC6A2 P23975 11/20 0.39
▸ SLC6A3 Q01959 7/20 0.38
▸ KCNH2 Q12809 5/20 0.37
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ CYP2D6 P10635 1/20 0.33
▸ BRD4 O60885 2/20 0.33
▸ ATAD2 Q6PL18 2/20 0.33
▸ NR1H4 Q96RI1 1/20 0.33
▸ CHRNB2 P17787 1/20 0.32
▸ CHRNA4 P43681 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301418 0.87 SLC6A4 (0.39) SLC6A4SLC6A2SLC6A3KCNH2KDM4E
SCHEMBL11301394 0.80 SLC6A2 (0.40) SLC6A4SLC6A2SLC6A3KCNH2KDM4E
SCHEMBL11296509 0.79 KDR (0.43) SLC6A4SLC6A2SLC6A3KCNH2KDM4E
SCHEMBL11299107 0.75 HTT (0.40) SLC6A4SLC6A2SLC6A3KCNH2KDM4E
SCHEMBL11294789 0.75 BRD4 (0.50) SLC6A4SLC6A2BRD4ATAD2
SCHEMBL11304997 0.72 HDAC6 (0.33) SLC6A4SLC6A2SLC6A3KCNH2KDM4E
SCHEMBL28363673 0.72 NOTUM (0.43) SLC6A4SLC6A2SLC6A3KCNH2KDM4E
SCHEMBL18361035 0.67 NOTUM (0.46) KDM4EMEN1GAAMAPTMAPK1
SCHEMBL9293777 0.65 CHEK1 (0.54) SLC6A4SLC6A2SLC6A3KDM4EGAA
SCHEMBL4247136 0.64 CCR5 (0.51) SLC6A4SLC6A2SLC6A3KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback